The microbiome in non-alcoholic fatty liver disease: associations and implications.
作者信息
Lin Eugenia A, Barlow Gillian M, Mathur Ruchi
机构信息
GI Motility Program, Department of Medicine (Eugenia A. Lin, Gillian M. Barlow).
Division of Endocrine Diabetes and Metabolism (Ruchi Mathur), Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
出版信息
Ann Gastroenterol. 2014;27(2):181-183.
Abstract
摘要
相似文献
1
The microbiome in non-alcoholic fatty liver disease: associations and implications.非酒精性脂肪性肝病中的微生物组：关联与影响
Ann Gastroenterol. 2014;27(2):181-183.
2
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease.肠道微生物组和饮食在非酒精性脂肪性肝病发病机制中的作用。
Clin Mol Hepatol. 2021 Jan;27(1):22-43. doi: 10.3350/cmh.2020.0129. Epub 2020 Dec 10.
3
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome.铁状态通过肠道微生物群影响肥胖的非酒精性脂肪肝疾病。
Microbiome. 2021 May 7;9(1):104. doi: 10.1186/s40168-021-01052-7.
4
Non-alcoholic fatty liver and the gut microbiota.非酒精性脂肪肝与肠道微生物群
Mol Metab. 2016 Jun 14;5(9):782-94. doi: 10.1016/j.molmet.2016.06.003. eCollection 2016 Sep.
5
Helicobacter pylori and non-alcoholic fatty liver disease.幽门螺杆菌与非酒精性脂肪性肝病。
Minerva Gastroenterol Dietol. 2020 Sep;66(3):267-279. doi: 10.23736/S1121-421X.20.02671-9.
6
Future therapy for non-alcoholic fatty liver disease.非酒精性脂肪性肝病的未来治疗方法。
Liver Int. 2018 Feb;38 Suppl 1:56-63. doi: 10.1111/liv.13676.
7
Bile acids associate with specific gut microbiota, low-level alcohol consumption and liver fibrosis in patients with non-alcoholic fatty liver disease.胆汁酸与非酒精性脂肪性肝病患者的特定肠道微生物群、低水平饮酒及肝纤维化相关。
Liver Int. 2020 Jun;40(6):1356-1365. doi: 10.1111/liv.14453. Epub 2020 Apr 24.
8
Characterization of Gut Microbiome in Korean Patients with Metabolic Associated Fatty Liver Disease.韩国代谢相关脂肪性肝病患者肠道微生物组的特征。
Nutrients. 2021 Mar 21;13(3):1013. doi: 10.3390/nu13031013.
9
Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.酒精性和非酒精性脂肪性肝病与冠状动脉钙化的关系：来自康伯三星健康研究的证据。
Gut. 2019 Sep;68(9):1667-1675. doi: 10.1136/gutjnl-2018-317666. Epub 2018 Nov 24.
10
Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis.细胞溶素阳性粪肠球菌在非酒精性脂肪性肝炎患者中并未增加。
Liver Int. 2020 Apr;40(4):860-865. doi: 10.1111/liv.14377. Epub 2020 Jan 23.
引用本文的文献
1
Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study.非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者小肠细菌过度生长综合征的患病率：一项横断面研究
Microorganisms. 2023 Mar 10;11(3):723. doi: 10.3390/microorganisms11030723.
2
Microbiome diurnal rhythmicity and its impact on host physiology and disease risk.微生物组的昼夜节律及其对宿主生理和疾病风险的影响。
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201847129. Epub 2019 Mar 15.
3
Gegen Qinlian Decoction Attenuates High-Fat Diet-Induced Steatohepatitis in Rats via Gut Microbiota.葛根芩连汤通过肠道菌群减轻高脂饮食诱导的大鼠脂肪性肝炎
Evid Based Complement Alternat Med. 2018 Dec 23;2018:7370891. doi: 10.1155/2018/7370891. eCollection 2018.
本文引用的文献
1
Bacterial community mapping of the mouse gastrointestinal tract.鼠类胃肠道细菌群落图谱。
PLoS One. 2013 Oct 7;8(10):e74957. doi: 10.1371/journal.pone.0074957. eCollection 2013.
2
Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease.非酒精性脂肪性肝病肥胖患者的粪便微生物组和挥发性有机化合物代谢组。
Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27.
3
Intestinal microbiota in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的肠道微生物群。
Hepatology. 2013 Jul;58(1):120-7. doi: 10.1002/hep.26319. Epub 2013 May 14.
4
The impact of the gut microbiota on human health: an integrative view.肠道微生物群对人类健康的影响：综合观点。
Cell. 2012 Mar 16;148(6):1258-70. doi: 10.1016/j.cell.2012.01.035.
5
Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanisms.益生菌作为一种新兴的治疗非酒精性脂肪性肝病（NAFLD）的治疗策略：聚焦分子和生化机制。
J Nutr Biochem. 2011 Aug;22(8):699-711. doi: 10.1016/j.jnutbio.2010.10.002. Epub 2011 Feb 2.
6
The role of the gut microbiota in nonalcoholic fatty liver disease.肠道微生物群在非酒精性脂肪性肝病中的作用。
Nat Rev Gastroenterol Hepatol. 2010 Dec;7(12):691-701. doi: 10.1038/nrgastro.2010.172. Epub 2010 Nov 2.
7
Microbial ecology: human gut microbes associated with obesity.微生物生态学：与肥胖相关的人类肠道微生物
Nature. 2006 Dec 21;444(7122):1022-3. doi: 10.1038/4441022a.
8
Metagenomic analysis of the human distal gut microbiome.人类远端肠道微生物群的宏基因组分析。
Science. 2006 Jun 2;312(5778):1355-9. doi: 10.1126/science.1124234.
9
Bile salt biotransformations by human intestinal bacteria.人类肠道细菌对胆汁盐的生物转化
J Lipid Res. 2006 Feb;47(2):241-59. doi: 10.1194/jlr.R500013-JLR200. Epub 2005 Nov 18.
10
Obesity alters gut microbial ecology.肥胖会改变肠道微生物生态。
Proc Natl Acad Sci U S A. 2005 Aug 2;102(31):11070-5. doi: 10.1073/pnas.0504978102. Epub 2005 Jul 20.
Zotero 插件